Advertisement
Journal Article
TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
E. Piek, A. Moustakas, A. Kurisaki, C.H. Heldin, P. ten Dijke
Journal of Cell Science 1999 112: 4557-4568;

Summary

The capacities of different transforming growth factor-(beta) (TGF-(beta)) superfamily members to drive epithelial to mesenchymal transdifferentiation of the murine mammary epithelial cell line NMuMG were investigated. TGF-(beta)1, but not activin A or osteogenic protein-1 (OP-1)/bone morphogenetic protein-7 (BMP-7), was able to induce morphological transformation of NMuMG cells as shown by reorganisation of the actin cytoskeleton and relocalisation/downregulation of E-cadherin and (beta)-catenin, an effect that was abrogated by the more general serine/threonine kinase and protein kinase C inhibitor, staurosporine. TGF-(beta)1 bound to TGF-(beta) type I receptor (T(beta)R-I)/ALK-5 and T(beta)R-II, but not to activin type I receptor (ActR-I)/ALK-2. Activin A bound to ActR-IB/ALK-4 and ActR-II, and BMP-7 bound to ActR-I/ALK-2, BMP type I receptor (BMPR-I)/ALK-3, ActR-II and BMPR-II. TGF-(beta)1 and BMP-7 activated the Smad-binding element (SBE)(4) promoter with equal potency, whereas activin A had no effect. Transfection of constitutively active (CA)-ALK-4 activated the 3TP promoter to the same extent as TGF-(beta)1 and CA-ALK-5 indicating that activin signalling downstream of type I receptors was functional in NMuMG cells. In agreement with this, activin A induced low levels of plasminogen activator inhibitor I expression compared to the high induction by TGF-(beta)1. In contrast to activin A and BMP-7, TGF-(beta)1 strongly induced Smad2 phosphorylation. Consistent with these findings, TGF-(beta)1 induced the nuclear accumulation of Smad2 and/or Smad3. In addition, NMuMG cells transiently infected with adenoviral vectors expressing high level CA-ALK-5 exhibited full transdifferentiation. On the other hand, infections with low level CA-ALK-5, which alone did not result in transdifferentiation, together with Smad2 and Smad4, or with Smad3 and Smad4 led to transdifferentiation. In conclusion, TGF-(beta)1 signals potently and passes the activation threshold to evoke NMuMG cell transdifferentiation. The TGF-(beta) type I receptor (ALK-5) and its effector Smad proteins mediate the epithelial to mesenchymal transition. Activin A does not induce mesenchymal transformation, presumably because the number of activin receptors is limited, while BMP-7-initiated signalling cannot mediate transdifferentiation.

REFERENCES

    1. Chen, Y.-G.,
    2. Hata, A.,
    3. Lo, R. S.,
    4. Wotton, D.,
    5. Shi, Y.,
    6. Pavletich, N. and
    7. Massague, J.
    (1998). Determinants of specificity in TGF-signal transduction. Genes Dev 12, 2144–2152
    OpenUrlAbstract/FREE Full Text
    1. Chen, Y.-G. and
    2. Massague, J.
    (1999). Smad1 recognition and activation by the ALK1 group of transforming growth factor-family receptors. J. Biol. Chem 274, 3672–3677
    OpenUrlAbstract/FREE Full Text
    1. Cui, W.,
    2. Fowlis, D. J.,
    3. Bryson, S.,
    4. Duffie, E.,
    5. Ireland, H.,
    6. Balmain, A. and
    7. Akhurst, R. J.
    (1996). TGF1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531–542
    OpenUrlCrossRefPubMedWeb of Science
    1. Caulin, C.,
    2. Scholl, F. G.,
    3. Frontelo, P.,
    4. Gamallo, C. and
    5. Quintanilla, M.
    (1995). Chronic exposure of cultured transformed epidermal cells to transforming growth factor1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 6, 1027–1035
    OpenUrlAbstract
    1. Feng, X. H. and
    2. Derynck, R.
    (1997). A kinase subdomain of transforming growth factor-(TGF-) type I receptor determines the TGF-intracellular signaling activity. EMBO J 16, 3912–3922
    OpenUrlAbstract
    1. Franzen, P.,
    2. ten Dijke, P.,
    3. Ichijo, H.,
    4. Yamashita, H.,
    5. Schulz, P.,
    6. Heldin, C.-H. and
    7. Miyazono, K.
    (1993). Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75, 681–692
    OpenUrlCrossRefPubMedWeb of Science
    1. Frolik, C. A.,
    2. Wakefield, L. M.,
    3. Smith, D. M. and
    4. Sporn, M. B.
    (1984). Characterization of a membrane receptor for transforming growth factor-in normal rat kidney fibroblasts. J. Biol. Chem 25, 10995–11000
    OpenUrl
    1. Hata, A.,
    2. Shi, Y. and
    3. Massague, J.
    (1998). TGF-signaling and cancer: structural and functional consequences of mutations in Smads. Mol. Med. Today 4, 257–262
    OpenUrlCrossRefPubMedWeb of Science
    1. Heine, U. I.,
    2. Munoz, E. F.,
    3. Flanders, K. C.,
    4. Roberts, A. B. and
    5. Sporn, M. B.
    (1990). Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. Development 109, 29–36
    OpenUrlAbstract
    1. Heldin, C.-H.,
    2. Miyazono, K. and
    3. ten Dijke, P.
    (1997). TGF-signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465–471
    OpenUrlCrossRefPubMedWeb of Science
    1. Hogan, B. L. M. and
    2. Yingling, J. M.
    (1998). Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr. Opin. Genet. Dev 8, 481–486
    OpenUrlCrossRefPubMedWeb of Science
    1. Hogan, B. L. M.
    (1999). Morphogenesis. Cell 96, 225–233
    OpenUrlCrossRefPubMedWeb of Science
    1. Jonk, L. J. C.,
    2. Itoh, S.,
    3. Heldin, C.-H.,
    4. ten Dijke, P. and
    5. Kruijer, W.
    (1998). Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-, activin and bone morphogenetic protein-inducible enhancer. J. Biol. Chem 273, 21145–21152
    OpenUrlAbstract/FREE Full Text
    1. Kingsley, D.
    (1994). The TGF-superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 8, 133–146
    OpenUrlFREE Full Text
    1. Labbe, E.,
    2. Silvestri, C.,
    3. Hoodless, P. A.,
    4. Wrana, J. L. and
    5. Attisano, L.
    (1998). Smad2 and Smad3 positively and negatively regulate TGF-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell 2, 109–120
    OpenUrlCrossRefPubMedWeb of Science
    1. Link, B. A. and
    2. Nishi, R.
    (1997). Opposing effects of activin A and follistatin on developing skeletal muscle cells. Exp. Cell. Res 233, 350–362
    OpenUrlCrossRefPubMedWeb of Science
    1. Macías-Silva, M.,
    2. Hoodless, P. A.,
    3. Tang, S. J.,
    4. Buchwald, M. and
    5. Wrana, J. L.
    (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem 273, 25628–25636
    OpenUrlAbstract/FREE Full Text
    1. Massague, J.
    (1998). TGF-signal transduction. Annu. Rev. Biochem 67, 753–791
    OpenUrlCrossRefPubMedWeb of Science
    1. Miettinen, P. J.,
    2. Ebner, R.,
    3. Lopez, A. R. and
    4. Derynck, R.
    (1994). TGF-induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol 127, 2021–2036
    OpenUrlAbstract/FREE Full Text
    1. Miyake, S.,
    2. Makimura, M.,
    3. Kanagae, Y.,
    4. Harada, S.,
    5. Sato, Y.,
    6. Takamori, K.,
    7. Tokuda, C. and
    8. Saito, I.
    (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmidbearing the full length viral genome. Proc. Nat. Acad. Sci. USA 93, 1320–1324
    OpenUrlAbstract/FREE Full Text
    1. Moustakas, A. and
    2. Stournaras, C.
    (1999). Regulation of actin organisation by TGF-in H-ras transformed fibroblasts. J. Cell Sci 112, 1169–1179
    OpenUrlAbstract/FREE Full Text
    1. Nakao, A.,
    2. Imamura, T.,
    3. Souchelnytskyi, S.,
    4. Kawabata, M.,
    5. Ishisaki, A.,
    6. Oeda, E.,
    7. Tamaki, K.,
    8. Hanai, J.-I.,
    9. Heldin, C.-H.,
    10. Miyazono, K. and
    11. ten Dijke, P.
    (1997). TGF-receptor-mediated signalling through Smad2, Smad3, and Smad4. EMBO J 16, 5353–5362
    OpenUrlAbstract
    1. Nishihara, T.,
    2. Okahashi, N. and
    3. Ueda, N.
    (1993). Activin A induces apoptotic cell death. Biochem. Biophys. Res. Commun 197, 985–991
    OpenUrlCrossRefPubMedWeb of Science
    1. Oft, M.,
    2. Peli, J.,
    3. Rudaz, C.,
    4. Schwarz, H.,
    5. Beug, H. and
    6. Reichmann, E.
    (1996). TGF-1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10, 2462–2477
    OpenUrlAbstract/FREE Full Text
    1. Oft, M.,
    2. Heider, K. H. and
    3. Beug, H.
    (1998). TGFsignaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol 8, 1243–1252
    OpenUrlCrossRefPubMedWeb of Science
    1. Ohtsuki, M. and
    2. Massague, J.
    (1992). Evidence for the involvement of protein kinase activity in transforming growth factor-signal transduction. Mol. Cell. Biol 12, 261–265
    OpenUrlAbstract/FREE Full Text
    1. Persson, U.,
    2. Izumi, H.,
    3. Souchelnytskyi, S.,
    4. Itoh, S.,
    5. Grimsby, S.,
    6. Engström, U.,
    7. Heldin, C.-H.,
    8. Funa, K. and
    9. ten Dijke, P.
    (1998). The L45 loop in type I receptors for TGF-family members is a critical determinant in specifying Smad isoform activation. FEBS Lett 434, 83–87
    OpenUrlCrossRefPubMedWeb of Science
    1. Piek, E.,
    2. Franzen, P.,
    3. Heldin, C.-H. and
    4. ten Dijke, P.
    (1997). Characterization of a 60-kDa cell surface-associated transforming growth factor-binding protein that can interfere with transforming growth factor- receptor binding. J. Cell. Physiol 173, 447–459
    OpenUrlCrossRefPubMed
    1. Piek, E.,
    2. Westermark, U.,
    3. Kastemar, M.,
    4. Heldin, C.-H.,
    5. van Zoelen, E. J. J.,
    6. Nister, M. and
    7. ten Dijke, P.
    (1999). Expression of transforming growth factor (TGF)-receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF- 1. Int. J. Cancer 80, 756–763
    OpenUrlCrossRefPubMedWeb of Science
    1. Portella, G.,
    2. Cumming, S. A.,
    3. Liddell, J.,
    4. Cui, W.,
    5. Ireland, H.,
    6. Akhurst, R. J. and
    7. Balmain, A.
    (1998). Transforming growth factoris essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9, 393–404
    OpenUrlAbstract
    1. Qui, R. G.,
    2. Chen, J.,
    3. McCormick, F. and
    4. Symons, M.
    (1995). A role for Rho in Ras transformation. Proc. Nat. Acad. Sci. USA 92, 11781–11785
    OpenUrlAbstract/FREE Full Text
    1. Qui, R. G.,
    2. Abo, A.,
    3. McCormick, F. and
    4. Symons, M.
    (1997). Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation. Mol. Cell. Biol 17, 3449–3458
    OpenUrlAbstract/FREE Full Text
    1. Robinson, S. D.,
    2. Silberstein, G. B.,
    3. Roberts, A. B.,
    4. Flanders, K. C. and
    5. Daniel, C. W.
    (1991). Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 113, 867–878
    OpenUrlAbstract
    1. Rogers, S. A.,
    2. Ryan, G.,
    3. Purchio, A. F. and
    4. Hammerman, M. R.
    (1993). Metanephric transforming growth factor-1 regulates nephrogenesis in vitro. Am. J. Physiol 264, 996–1002
    OpenUrl
    1. Rosenzweig, B. L.,
    2. Imamura, T.,
    3. Okadome, T.,
    4. Cox, G. N.,
    5. Yamashita, H.,
    6. ten Dijke, P.,
    7. Heldin, C.-H. and
    8. Miyazono, K.
    (1995). Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Nat. Acad. Sci. USA 92, 7632–7636
    OpenUrlAbstract/FREE Full Text
    1. Seidel-Dugan, C.,
    2. Meyer, B. E.,
    3. Thomas, S. M. and
    4. Brugge, J. S.
    (1992). Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol 12, 1835–1845
    OpenUrlAbstract/FREE Full Text
    1. Silberstein, G. B. and
    2. Daniel, C. W.
    (1987). Reversible inhibition of mammary gland growth by transforming growth factor-1. Science 237, 291–293
    OpenUrlAbstract/FREE Full Text
    1. ten Dijke, P.,
    2. Yamashita, H.,
    3. Ichijo, H.,
    4. Franzen, P.,
    5. Laiho, M.,
    6. Miyazono, K. and
    7. Heldin, C.-H.
    (1994). Characterization of type I receptors for transforming growth factor-and activin. Science 264, 101–104
    OpenUrlAbstract/FREE Full Text
    1. Torii, Y.,
    2. Hitomi, K. and
    3. Tsukagoshi, N.
    (1996). Synergistic effect of BMP-2 and ascorbate on the phenotypic expression of osteoblastic MC3T3-E1 cells. Mol. Cell. Biochem 165, 25–29
    OpenUrlPubMedWeb of Science
    1. Wennström, S.,
    2. Hawkins, P.,
    3. Cooke, F.,
    4. Hara, K.,
    5. Yonezawa, K.,
    6. Kasuga, M.,
    7. Jackson, T.,
    8. Claesson-Welsh, L. and
    9. Stephens, L.
    (1994). Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol 4, 385–393
    OpenUrlCrossRefPubMedWeb of Science
    1. Whitman, M.
    (1998). Smads and early developmental signaling by the TGFsuperfamily. Genes Dev 12, 2445–2462
    OpenUrlFREE Full Text
    1. Wrana, J. L.,
    2. Attisano, L.,
    3. Wieser, R.,
    4. Ventura, F. and
    5. Massague, J.
    (1994). Mechanism of activation of the TGF-receptor. Nature 370, 341–347
    OpenUrlCrossRefPubMedWeb of Science
    1. Yamashita, H.,
    2. ten Dijke, P.,
    3. Huylebroeck, D.,
    4. Sampath, T. K.,
    5. Andries, M.,
    6. Smith, J. C.,
    7. Heldin, C.-H. and
    8. Miyazono, K.
    (1995). Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol 130, 217–226
    OpenUrlAbstract/FREE Full Text
Back to top

 Download PDF

Email
Journal Article
TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
E. Piek, A. Moustakas, A. Kurisaki, C.H. Heldin, P. ten Dijke
Journal of Cell Science 1999 112: 4557-4568;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article navigation

Other journals from The Company of Biologists

Advertisement

2020 at The Company of Biologists

Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.

Mole – The Corona Files

"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.

Cell scientist to watch – Christine Faulkner

In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.

Read & Publish participation extends worldwide

“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”

Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.

JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.